SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000906709-22-000010
Filing Date
2022-05-06
Accepted
2022-05-05 20:24:16
Documents
55
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nktr-20220331.htm   iXBRL 10-Q 1044312
2 EX-31.1 nktr2022-03x31xexx311.htm EX-31.1 9508
3 EX-31.2 nktr2022-03x31xexx312.htm EX-31.2 9522
4 EX-32.1 nktr2022-03x31xexx321.htm EX-32.1 6025
  Complete submission text file 0000906709-22-000010.txt   4573613

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktr-20220331.xsd EX-101.SCH 37105
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nktr-20220331_cal.xml EX-101.CAL 58838
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nktr-20220331_def.xml EX-101.DEF 153919
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktr-20220331_lab.xml EX-101.LAB 423590
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktr-20220331_pre.xml EX-101.PRE 266505
49 EXTRACTED XBRL INSTANCE DOCUMENT nktr-20220331_htm.xml XML 606096
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 22898450
SIC: 2834 Pharmaceutical Preparations